Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothalamo-Hypophyseal System | 1 | 2024 | 19 | 0.940 |
Why?
|
| Pituitary-Adrenal System | 1 | 2024 | 20 | 0.940 |
Why?
|
| Thymus Gland | 1 | 2024 | 53 | 0.920 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 21 | 0.790 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 342 | 0.760 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 50 | 0.740 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 9 | 0.660 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 13 | 0.660 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 93 | 0.620 |
Why?
|
| Signal Transduction | 2 | 2021 | 1339 | 0.590 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 17 | 0.500 |
Why?
|
| Mutation | 1 | 2019 | 819 | 0.500 |
Why?
|
| Hemolysis | 1 | 2015 | 46 | 0.490 |
Why?
|
| Research Design | 1 | 2015 | 173 | 0.450 |
Why?
|
| Neoplasms | 1 | 2019 | 750 | 0.360 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 2 | 0.210 |
Why?
|
| Rhabdomyosarcoma | 1 | 2022 | 3 | 0.210 |
Why?
|
| Endopeptidase Clp | 1 | 2021 | 9 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 1259 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 100 | 0.190 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 115 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 143 | 0.190 |
Why?
|
| Humans | 6 | 2024 | 26838 | 0.180 |
Why?
|
| Phosphorylation | 2 | 2019 | 557 | 0.180 |
Why?
|
| Animals | 3 | 2024 | 9949 | 0.180 |
Why?
|
| Escherichia coli Proteins | 1 | 2021 | 113 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2021 | 245 | 0.170 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 23 | 0.170 |
Why?
|
| Serine | 1 | 2019 | 47 | 0.170 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Cell Line | 1 | 2021 | 671 | 0.160 |
Why?
|
| Escherichia coli | 1 | 2021 | 328 | 0.160 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 10 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 674 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 450 | 0.140 |
Why?
|
| Age Factors | 1 | 2015 | 716 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2015 | 848 | 0.100 |
Why?
|
| Infant | 1 | 2015 | 963 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2015 | 1090 | 0.100 |
Why?
|
| Child | 1 | 2015 | 2152 | 0.080 |
Why?
|
| Protein Binding | 2 | 2021 | 631 | 0.070 |
Why?
|
| Adolescent | 1 | 2015 | 2958 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2022 | 1 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 131 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 28 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2021 | 149 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2021 | 441 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 766 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2018 | 14 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 196 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 131 | 0.040 |
Why?
|
| Proteomics | 1 | 2018 | 177 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 748 | 0.030 |
Why?
|
| Mice | 1 | 2022 | 4401 | 0.030 |
Why?
|